Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC

NCT02709720 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Vinorelbine
DRUG: Cisplatin
DRUG: Vinorelbine
DRUG: Cisplatin
RADIATION: Radiotherapy

Sponsor

Spanish Lung Cancer Group